Chapman Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71M Hold
5,406
1.8% 12
2026
Q1
$2.66M Sell
5,406
-23
-0.4% -$12.5K 1.9% 10
2025
Q4
$3.15M Hold
5,429
2.14% 8
2025
Q3
$2.63M Buy
5,429
+497
+10% +$231K 1.82% 10
2025
Q2
$2M Buy
+4,932
New +$2.06M 1.7% 14
2024
Q4
$2.63M Buy
+5,058
New +$2.78M 2.11% 9

Other funds holding TMO

Chapman Financial Group's TMO Position: Q2 2026 in Review

Chapman Financial Group held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 5,406 shares worth $2.71M. The position accounts for 1.8% of the portfolio, ranked #12.

Chapman Financial Group first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.15M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Chapman Financial Group held 5,406 shares of Thermo Fisher Scientific worth $2.71M as of Q2 2026.
  • Chapman Financial Group left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 1.8% of Chapman Financial Group's portfolio in Q2 2026, its #12 holding.
  • Chapman Financial Group first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Chapman Financial Group's Thermo Fisher Scientific position peaked at $3.15M in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Chapman Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.